INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver cancers: targeted chemo plus immune booster
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard liver-directed chemotherapy can help people with certain cancers that have spread to the liver. About 70 adults with colorectal, bile duct, or adrenal cancer will receive treatment through a pump place…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:16 UTC
-
Triple-drug attack shows promise against hard-to-treat liver cancer
Disease control Recruiting nowThis study tests a combination of two targeted drugs (apatinib and adebrelimab) plus chemotherapy (GEMOX) as a first treatment for people with advanced intrahepatic cholangiocarcinoma (ICC), a type of bile duct cancer that cannot be removed by surgery. The goal is to see if this …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 26, 2026 07:08 UTC
-
New triple therapy aims to shrink hard-to-treat liver cancer
Disease control Recruiting nowThis study tests a new first-line treatment for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that cannot be removed by surgery. The treatment combines chemotherapy directly into the liver artery (HAIC) with two drugs: durvalumab (an immunothera…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New scan could spot bile duct cancers more accurately
Diagnosis Recruiting nowThis study looks at whether a new type of PET scan called FAPI can find and stage gallbladder and bile duct cancers better than the standard scan. About 60 adults with suspected or confirmed cancer will get both scans so doctors can compare accuracy. The goal is to improve detect…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Tata Memorial Centre • Aim: Diagnosis
Last updated May 26, 2026 06:52 UTC
-
Blood test breakthrough could catch deadly bile duct cancers early
Diagnosis Recruiting nowThis study is testing a new blood test that looks for DNA changes from tumors to detect biliary tract cancers (cancers of the bile ducts and gallbladder). These cancers are often found late and have a low survival rate. The test aims to find them earlier and help doctors monitor …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated May 20, 2026 11:56 UTC
-
New PET scan tracer could spot Hard-to-Find cancers
Diagnosis Recruiting nowThis study tests a new radioactive tracer called 89Zr-TLX250 to see if it can better detect liver cancer, bile duct cancer, and certain neuroendocrine tumors on PET-CT scans. The tracer targets a protein (CAIX) found on these cancer cells. Researchers will compare the number and …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated May 18, 2026 12:02 UTC
-
New scout dose method could make liver cancer treatment safer for lungs
Knowledge-focused Recruiting nowThis study involves 30 adults with liver tumors who are scheduled for radioembolization, a treatment that delivers radiation directly to the tumor. Doctors want to see if using a small 'scout dose' of the actual treatment beads can more accurately measure how much radiation might…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC